The largest database of trusted experimental protocols

1290 infinity 2 liquid

Manufactured by Agilent Technologies
Sourced in United States

The 1290 Infinity II liquid chromatography system is a high-performance liquid chromatography (HPLC) instrument designed for analytical and preparative applications. It features a modular design, allowing for the integration of various components such as pumps, autosamplers, and detectors to create a customized solution. The system is capable of delivering precise and accurate solvent flow rates, ensuring reliable and reproducible results.

Automatically generated - may contain errors

2 protocols using 1290 infinity 2 liquid

1

Stability Characterization of Antibody Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
To characterize the in vitro stability of abEC1.1 and abEC1.1m by SEC (Fekete et al., 2014 (link); Bobaly et al., 2017 (link)), eppendorf tubes containing 4.2 mg/mL of antibody per tube were incubated at 4°C, room temperature (∼22°C), 37°C and 42°C for 3, 5, 7 and 16 days. At each time point, 20 μL of solution were loaded into a Nanofilm SEC-250 column (Sepax Technologies, Inc., DW, United States) and processed at flow-rates of 0.5 mL/min using a 1290 Infinity II liquid chromatography system (Agilent Technologies, Santa Clara, CA, United States). Raw data generated by the instrument (optical density, OD, measured at 405 nm vs. retention time) were normalized to the peak of each chromatogram and plotted using OriginPro 2017 software (OriginLab, Northampton, MA, United States).
+ Open protocol
+ Expand
2

Highly Sensitive Liquid Chromatography-Tandem Mass Spectrometry for Compound Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Media samples (10 μL) were chromatographed on a ZORBAX SSHD Eclipse Plus C18 column (3×50 mm, 1.8 μm, 959757-302; Agilent, Santa Clara, CA) with a guard column (2.1×5 mm, 1.8 μm, 821725-901; Agilent) using 1290 Infinity II liquid chromatograph (LC; Agilent). Column temperature and the LC flow rate were set at 40°C and 0.4 ml/min. Initial chromatographic condition was maintained at 90% mobile phase A (water with 0.1% formic acid, v/v) and 10% mobile phase B (acetonitrile with 0.1% formic acid, v/v) for one min, then increased to 80% B by 3 min, then to 95% B by 4 min, and then returned to initial condition at 5 min until 8 min for sufficient equilibrium. Unmodified mobile phases A (water) and B (acetonitrile) were used for the analysis of Troglitazone.
MS/MS analyses were performed in positive ion mode (all test drugs except Troglitazone) or negative ion mode (for Troglitazone) with an electrospray ionization (ESI) source using 6470 triple-quadruple MS (Agilent). The capillary voltage was set at 3500 V. The nebulizer gas pressure and gas temperature were set at 35 psi and 350°C, respectively. The MS/MS parameters for each test compound are summarized in Supplemental Table 1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!